Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Chinese Bird Flu Vaccine For Humans Clears Phase II Trials (China)

This article was originally published in PharmAsia News

Executive Summary

Sinovac Biotech said its bird flu vaccine for use in humans has passed Phase II clinical trials without affecting any of the 402 participants. Zhang Jiansan, vice-general manager of the Beijing-based firm, said the test results indicate the vaccine could offer several choices for treatment. The executive also said the nation is capable of producing an appropriate quantity of the vaccine should it be needed. Zhang said the company was able to control the dosage and immunity procedure for the vaccine during the trials, adding to enhanced scientific and effective methods for combating the disease. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts